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essari et al. (1) elegantly demonstrated—by
a precursor-product stable isotope method—
independent contributions of age, type 2 diabetes,
and asymmetric dimethylarginine (ADMA) to im-
paired conversion of 15N-labeled L-arginine into nitrite and
nitrate (NOx), products of nitric oxide (NO) metabolism.
Interestingly, the authors observed no associations of any
parameter of NOx kinetics with insulin sensitivity by a
hyperinsulinemic-euglycemic clamp technique (1).
Our group was the first to report elevated plasma ADMA
in uncomplicated essential hypertension (EH), an insulin-
resistant state (2). Additionally, in our hands, in some
analogy to Tessari et al. (1), reduced urinary NOx excretion,
a surrogate measure of NO generation, was associated
with EH by itself and a decreased L-arginine-to-ADMA
ratio, being unrelated to clamp-derived indices of accom-
panying insulin resistance (IR) (2).
Therefore, it does not seem implausible to assume that
NO deficiency in insulin-resistant conditions, such as EH
and type 2 diabetes, may be linked not to the magnitude
of IR but to other mechanisms, such as ADMA accumu-
lation. Inasmuch as whole-body NO formation can putatively
reflect endothelial function, these findings (1,2) appear
consistent with associations of ADMA, but not IR, with
impaired endothelium-dependent vasodilation in EH (3) and
early coronary atherosclerosis (4).
The proposed hypothesis is contradictory to the notion
of NO—liberated by endothelial cells in response to insulin
via the Akt-dependent pathway (5)—coupling glucose me-
tabolism to vasodilation in skeletal muscle (6). However,
Kearney (5) has recently summarized novel evidence sup-
porting the dissociation of metabolic sensitivity to insulin
from endothelial NO release and its vasculoprotective
effects.
Nevertheless, NOx assay does not allow differentiation
between biologically active NO and that scavenged by
superoxide, which might obscure the correlation between
IR and depressed NO bioavailability. Sukumar et al. (7)
described the dependence of IR-induced endothelial dys-
function on enhanced superoxide generation by a NADPH
oxidase. Hence, further mechanistic studies on impaired
NO bioavailability in IR states are warranted.
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